Zhejiang R.G.B Textile Printing and Dyeing has been sold to Actis
Lincoln International (“Lincoln”), a leading global mid-market investment bank, is pleased to announce that Zhejiang R.G.B Textile Printing and Dyeing Co., LTD (“RGB” or the “Company”) has completed the sale of a majority stake to Actis. Terms of the transaction were not disclosed.
RGB is a specialized textile fabric company in China. The Company was founded in 2004 by husband and wife team, Victor Chen and current CEO Christina Sheng. RGB’s fabrics are now sold in over 80 countries through a network of distributors. The Company is one of the global leaders in providing women’s specialized fabric in the Middle East and Africa markets. Unlike many competitors, who are primarily engaged in processing and have limited design capabilities, RGB is distinguished for its strong in-house design capability, with over 90% of sales from patterns designed in-house.
Max Lin, a director in the private equity business at Actis, said, “RGB is an enormously exciting opportunity. China has long been the world leader in exporting fabrics and we believe that RGB has a differentiated offering with strong capabilities which will help it grow into untapped markets.”
Christina Sheng, CEO of RGB, said, “Actis has a great track record of investing alongside businesses like ours. Together we will focus on identifying opportunities for growth and making them happen.”
Lincoln acted as the exclusive financial advisor to RGB and its shareholders. Lincoln worked closely with the shareholders and the management team throughout the sale process by providing mergers and acquisitions advisory expertise, preparing marketing materials and data room, contacting and coordinating with both international and domestic investors, advising on negotiations and supporting the process, including regulatory approvals, until the closing of the transaction.
Meet our Senior Team
Working with courageous leaders who have a vision, and fearlessly work towards achieving their vision, is what inspires me.
Senior Advisor and Chairman ChinaBeijing
I enjoy being involved and working on the fast-growing M&A opportunities in China.
View More Transactions
Lincoln International is pleased to announce the successful sale of C³ (Cannabinoid Compound Company), a subsidiary of Bionorica SE, a producer and marketer of cannabis-based therapeutic compounds, to Canopy Growth
Lincoln is pleased to announce that it has advised Riello Investimenti SGR on the sale of Trafimet Group to Kemppi Oy
Lincoln International is pleased to have advised Tikehau Capital on its £23 million minority investment into Medtrade, a UK based manufacturer of advanced woundcare and consumer healthcare products
Lincoln International is pleased to announce the successful completion of a $20 million Series C financing round for Rapid Medical